Melinta Therapeutics Inc. (MLNT) Declined -5.46% or -0.06 To Price $1.04 On Wednesday


Melinta Therapeutics Inc. (MLNT) declined -5.46% or -0.06 to $1.04. It is near to 672825 shares traded, which is 88.18% compare to the average total volume 762993. The market cap of MLNT is $58.26 million. The year to date change is -3.6%. The 52 week price range is from $0.64 to $17.25. Price of MLNT have changed 1.85% during last week. It have changed -29.03% over last month, -73.93% over last 3 months, -83.70% over last 6 months and -93.51% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MLNT is 1.99. It is 91.35% above current price. The 200-day Moving Averages for MLNT is 5.02. It is 382.69% above current price. The 52-week High is 17.25. It is 1558.65% from the current price. The 52-week Low is 0.64. It is -38.46% from current price.

There are some statistics of MLNT. It is has market cap $58.26 million. The share outstanding is 56.02 million. The average volume is 762993. The percent of top 15 Institution holding is 88.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MLNT is -71.09%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MLNT is -40.57%.


Tags:

Share this post